Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2005
10/27/2005US20050238619 Method for the delivery of sustained release agents
10/27/2005US20050238617 Methods for increasing protein polyethylene glycol (PEG) conjugation
10/27/2005US20050238607 FGF-5 supported and binding peptides
10/27/2005US20050238579 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
10/27/2005DE102004018347A1 Wundheilungsfördende Botenstoffmischung Wundheilungsfördende messenger mixture
10/27/2005CA2563578A1 Diagnostic and therapeutic applications of soluble lhcgr protein
10/27/2005CA2563408A1 Annexin v for preventing atherothrombois and plaque rupture
10/27/2005CA2563390A1 Compounds that block the c5a receptor and their use in therapy
10/27/2005CA2563332A1 Therapeutic uspa1-derived peptides
10/27/2005CA2562937A1 Use of peptidic compounds for the prophylaxis and treatment of chronic headache
10/27/2005CA2562892A1 Bob-1 specific t cells and methods to use
10/27/2005CA2562890A1 Novel g-csf conjugates
10/27/2005CA2562885A1 Follistatin variant polypeptide
10/27/2005CA2562829A1 Oxygenated dibenzo-alpha-pyrone chromoproteins
10/27/2005CA2562495A1 Use of glycerol dipalmitostearate for improving the bioavailability of protein active ingredients in subcutaneous or intramuscular injectable formulations
10/27/2005CA2562193A1 Treatment of neuropathic pain with zinc finger proteins
10/27/2005CA2561877A1 Use of mic-1 or modulating agent thereof to modulate appetite or body weight
10/27/2005CA2561565A1 Methods for repression of phospholamban gene and modulating cardiac contractility
10/27/2005CA2561494A1 Diagnosis and treatment of myeloid and lymphoid cell cancers
10/26/2005EP1589109A2 VMP-like sequences of pathogenic borrelia
10/26/2005EP1589108A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
10/26/2005EP1589100A1 Transcriptional activator
10/26/2005EP1589029A2 Pyrazinone protease inhibitors
10/26/2005EP1588727A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
10/26/2005EP1588726A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
10/26/2005EP1588716A1 Peg-urate oxidase conjugates and use thereof
10/26/2005EP1588712A1 Modulators of regulatory proteins
10/26/2005EP1588702A1 Azalide antibiotics for the topical treatment or prevention of ocular infections
10/26/2005EP1588172A2 Method for identifying bhs-specific proteins and fragments thereof
10/26/2005EP1588167A2 Sperm specific lysozyme-like proteins
10/26/2005EP1587944A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
10/26/2005EP1587926A2 Lipophilic derivatives of double-stranded ribonucleic acid
10/26/2005EP1587923A2 Improved constructs for expressing lysosomal polypeptides
10/26/2005EP1587921A2 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function
10/26/2005EP1587908A2 Cellular delivery and activation polypeptide-nucleic acid complexes
10/26/2005EP1587904A2 Glycosylation modified il-20
10/26/2005EP1587843A2 Combinatorial libraries of monomer domains
10/26/2005EP1587838A2 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation
10/26/2005EP1587834A2 Uses of mammalian cytokine; related reagents
10/26/2005EP1587830A1 Peptide inhibitors of toxins derived from ll-37
10/26/2005EP1587828A1 Defensin protins
10/26/2005EP1587827A1 Obesity-related genes
10/26/2005EP1587819A2 Isolation and purification procedure of vasopeptidase peptide inhibitors
10/26/2005EP1587574A2 SELECTIVE 11b-HSD INHIBITORS AND METHODS FOR USE THEREOF
10/26/2005EP1587544A1 p53 TREATMENT OF PAPILLOMARIVUS AND CARCINOGEN-TRANSFORMED CELLS IN HYPERPLASTIC LESIONS
10/26/2005EP1587535A2 Title of the invention n-cyclohexylaminocarbonyl benzenesulfonamide derivatives
10/26/2005EP1587534A1 Use of tff2, or agents inducing tff2, in the therapy of allergies
10/26/2005EP1587533A1 A hybrid vector system for use as a vaccine
10/26/2005EP1587532A2 Survivin-derived peptides and use thereof
10/26/2005EP1587531A2 Hcv combination therapy
10/26/2005EP1587530A2 The use of yop proteins or rho gtpase inhibitors as caspase-1 inhibitors
10/26/2005EP1587529A2 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
10/26/2005EP1587528A2 Methods of treating and/or preventing autoimmune diseases
10/26/2005EP1587527A1 Amino acid derived prodrugs of propofol, compositions and uses thereof
10/26/2005EP1587526A2 Mntf peptides and compositions and methods of use
10/26/2005EP1587525A2 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus
10/26/2005EP1587524A2 Compositions and methods for targeted biological delivery of molecular carriers
10/26/2005EP1587520A1 Bacteriophage for the treatment of bacterial biofilms
10/26/2005EP1587510A1 Method for treating ischemic stroke with melatonin
10/26/2005EP1587484A2 Method of treating angiogenic tissue growth
10/26/2005EP1587483A2 Methods for modulating an inflammatory response
10/26/2005EP1587478A2 Pharmaceutical composition
10/26/2005EP1587405A2 Novel compositions and methods for cancer
10/26/2005EP1587404A2 Pigment epithelium derived factor from human plasma and methods of use thereof
10/26/2005EP1509540A4 Claudin polypeptides, polynucleotides, and methods of making and use thereof
10/26/2005EP1458847A4 Novel nucleic acids, polypeptides, methods of making, and uses thereof
10/26/2005EP1444264A4 Methods and materials for targeting and affecting selected cells
10/26/2005EP1169059B1 Docetaxel in combination with rhumab her2 for the treatment of cancers
10/26/2005EP1159455B1 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE
10/26/2005EP1140148B1 Shelf-stable solution formulation of glucagon-like peptide-1
10/26/2005EP1140000B1 Cosmetic or dermatological composition containing an active principle stimulating hsp 32 protein synthesis in the skin and cosmetic treatment method
10/26/2005EP1137426B1 Breast cancer treatment using natural plant essential oils
10/26/2005EP1087778B1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
10/26/2005EP1073415B1 Pharmaceutical compositions capable of being gelled
10/26/2005EP0975357B1 Transdermal delivery system
10/26/2005EP0975226B1 Cell-coated supports
10/26/2005EP0963437B1 The process for the expression and production of the recombinant human beta-cis interferon
10/26/2005EP0916681B1 Neuropeptides originating in scorpion
10/26/2005EP0909273B1 Alpha-amylase transcription factor
10/26/2005EP0762880B1 Retroviral protease inhibitor combinations
10/26/2005EP0711303B1 Biotinylation of proteins
10/26/2005EP0625048B2 Synthesis of human procollagens and collagens in recombinant dna systems
10/26/2005EP0506757B2 A recombinant human factor viii derivative
10/26/2005CN1688701A Mechanisms of myoblast transfer in treating heart failure
10/26/2005CN1688696A GHRH analogues
10/26/2005CN1688603A Treatment and prophylaxis with 4-1BB-binding agents
10/26/2005CN1688602A Novel MHC II associated peptides
10/26/2005CN1688601A Nuclear factor of activated T cells receptor
10/26/2005CN1688600A Template-fixed peptidomimetics with antibacterial activity
10/26/2005CN1688599A Use of dipeptidyl peptidase IV inhibitor
10/26/2005CN1688364A Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer
10/26/2005CN1688348A Hemostatic dressing
10/26/2005CN1688340A Methods and compositions for modulating T helper (TH) cell development and function
10/26/2005CN1688332A Propagation increasing action of osteogenic growth peptide to hemopoietic progenitor cell and application
10/26/2005CN1688325A Black soybean polysaccharides
10/26/2005CN1688323A Lentiviral vector-mediated gene transfer and uses thereof
10/26/2005CN1688303A Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
10/26/2005CN1688294A Enteric composition for the manufacture of soft capsule wall
10/26/2005CN1688293A Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
10/26/2005CN1688279A Oral composition providing enhanced oral hygiene properties
1 ... 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 ... 3163